Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines

Experimental Lung Research

Volumn 24, Issue 1, 1998, Pages 3-14

  Kline, Joel N ^a,b   Hunninghake, G Matthew ^a   He, Bei ^a   Monick, Marty M ^a   Hunninghake, Gary W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HEALTH CARE   (United States)

Author keywords

Cytokine; Cytomegalovirus; Prostaglandin

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG POTENTIATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; INFLAMMATION; LUNG TRANSPLANTATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIRUS ACTIVATION; VIRUS INFECTION;

EID: 0031938299     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149809046050     Document Type: Article

References (18)

1. Miller W, Flynn P, McCullough J, Balfour HH, Goldman A, Haake R, McGlave P, Ramsay N, Kersey J. CMV infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood. 1986;67:1162-1167.
2. Burke CM, Glanville AR, Macoviak JA. The spectrum of CMV infection following human heart-lung transplantation. J Heart Transplant. 1986;5:267-272.
3. Grundy JE, Shanley JD, Shearer GM. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation. 1985;39:548-553.
4. Lonnqvist B, Ringden O, Wahren B, Gahrton G, Lundgren G. CMV infection associated with and preceding chronic graft-versus-host disease. Transplantation. 1984;38:465-468.
5. Reddchase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent CMV infection. J Exp Med. 1994;179:185-193.
6. Balthesen M, Messerle M, Reddchase MJ. Lungs are a major organ site of CMV latency and recurrence. J Virol. 1993;67:5360-5366.
7. Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN. Enhanced HIV-1 replication in Vb12 T cells due to human CMV in monocytes. Cell. 1995;82:753-763.
8. Stinski MF. Cytomegalovirus and its replication. In Fields BN, Knipe DM, eds. Virology. Raven Press: New York; 1990:1959-1980.
9. Hunninghake GW, Monick MM, Liu B, Stinski MF. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol. 1989;63:3026-3033.
10. Lacgrid A, Medvedev A, Nonstad U, Bombara MP, Ranges G. Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kB and induction of human cytomegalovirus enhancer. J Biol Chem. 1994;269:7785-7791.
11. Stinski MF, Roehr TJ. Activation of the major early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J Virol. 1985;55:431-441.
12. Tanaka J, Ogura T, Iida H, Sato H, Hatano M. Inhibitors of prostaglandin synthesis inhibit growth of human cytomegalovirus and reactivation of latent virus in a productively and lalently infected human cell line. Virol. 1988;163:205-208.
13. Newton AA. Inhibitors of prostaglandin synthesis as inhibitors of herpes simplex virus replication. Adv Ophthalmol. 1979;38:58-63.
14. Khyatti M, Menezes J. The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells. Antiviral Res. 1990;14:161-172.
15. AbuBakar S, Boldogh I, Albrecht T. Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. Biochem Biophys Res Commun. 1990;166:953-959.
16. Romaniuk A, Prop J, Petersen AH. Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantation. 1987;44:209-214.
17. Sambucetti LC, Cherrington JM, Wilkinson GWG, Mocarski ES. NK-kB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989;8: 4251-4258.
18. Macias MP, Stinski MF. An in vitro system for human CMV immediate early 2 protein-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter. Proc Natl Acad Sci USA. 1993;90:701-711.